Revenue
EPS
EBIT
Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: JPY
Unlock Free Earnings Estimates
Chugai Pharmaceutical: Confirmatory letter.
Jul 26 02:02 ET
Chugai Pharmaceutical: Interim report - 114th Period (01/01/2024 - 12/31/2024)
Jul 26 02:01 ET
Chugai Pharmaceutical: Confirmation letter
Jul 26 01:35 ET
Chugai Pharmaceutical: (Correction/Correction of numerical data) Correction of some parts of the "Fiscal Year ending December 2023 Consolidated Financial Statements [IFRS] (Consolidated)"
Jul 26 01:30 ET
Read more
Updated: Oct 14, 2024
Buy
Strong Buy
Hold
Underperform
Sell
No Data